Print this page
-
Post-Transplant Use of Irradiated Haplo-Allogeneic Cells
Protocol: 011702Principal Investigator:
- Roger Strair M.D., Ph.D. (Rutgers University)
Applicable Disease Sites: Lymphoid Leukemia
Multiple Myeloma
Leukemia, other
Non-Hodgkin's Lymphoma -
The Prophylactic Use of Loratadine for Granulocyte-Colony Stimulating Factor (G-CSF) Induced Bone Pain in Multiple Myeloma Patients Undergoing Stem Cell Mobilization.
Protocol: 011910Principal Investigator:
- Mansi Shah MD (Rutgers University)
Applicable Disease Sites: Multiple Myeloma
Bones and Joints
Ill-Defined Sites -
Leukemia Inhibitory Factor Levels after Allogeneic Transplantation
Protocol: 022104Principal Investigator:
- Roger Strair M.D., Ph.D. (Rutgers University)
Applicable Disease Sites: Leukemia, other
Leukemia, not otherwise specified -
Exploring Patient and Caregiver Perspectives and Experiences with Financial Toxicity
Protocol: 132105Principal Investigator:
- Biren Saraiya M.D (Rutgers University)
Applicable Disease Sites: Hodgkin's Lymphoma
Leukemia, other
Myeloid and Monocytic Leukemia
Leukemia, not otherwise specified -
Improving chemotherapy-induced nausea control through Bright Ideas?-CIN training: a feasibility study in children receiving oral chemotherapy
Protocol: 132104Principal Investigator:
- Katie Devine (Rutgers University)
Applicable Disease Sites: Leukemia, not otherwise specified
Leukemia, other -
Analysis of Circulating Lymphoid Cells in Patients With (or Treated For) Non-Hodgkin s Lymphoma
Protocol: 011811Principal Investigator:
- Roger Strair M.D., Ph.D. (Rutgers University)
Applicable Disease Sites: Non-Hodgkin's Lymphoma
